Please Wait
Applying Filters...

Filters
×
FILTER DATA :

filter

capsule-granulation|Capsule||solution-granulation|Solution||gel-granulation|Gel||emulsion-granulation|Emulsion||transdermal-patches-granulation|Transdermal patches

granules-granulation|Granule / Pellet

granules-granulation|Granule / Pellet||tablet-granulation|Tablet

orally-disintegrating-tablets-granulation|Orodispersible Tablet

orally-disintegrating-tablets-granulation|Orodispersible Tablet||tablet-granulation|Tablet||granules-granulation|Granule / Pellet

tablet-granulation|Tablet

tablet-granulation|Tablet||capsule-granulation|Capsule

tablet-granulation|Tablet||capsule-granulation|Capsule||granules-granulation|Granule / Pellet

tablet-granulation|Tablet||capsule-granulation|Capsule||granules-granulation|Granule / Pellet||softgels-granulation|Softgels

tablet-granulation|Tablet||capsule-granulation|Capsule||softgels-granulation|Softgels||granules-granulation|Granule / Pellet||topical-films-granulation|Topical Film

tablet-granulation|Tablet||capsule-granulation|Capsule||solution-granulation|Solution||gel-granulation|Gel||emulsion-granulation|Emulsion||topical-films-granulation|Topical Film

tablet-granulation|Tablet||granules-granulation|Granule / Pellet

tablet-granulation|Tablet||orally-disintegrating-tablets-granulation|Orodispersible Tablet||capsule-granulation|Capsule

tablet-granulation|Tablet||orally-disintegrating-tablets-granulation|Orodispersible Tablet||capsule-granulation|Capsule||granules-granulation|Granule / Pellet

tablet-granulation|Tablet||orally-disintegrating-tablets-granulation|Orodispersible Tablet||capsule-granulation|Capsule||granules-granulation|Granule / Pellet||softgels-granulation|Softgels

tablet-granulation|Tablet||orally-disintegrating-tablets-granulation|Orodispersible Tablet||granules-granulation|Granule / Pellet||softgels-granulation|Softgels

filter

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

BASF

Corel Pharma Chem

Microlex e.U

Roquette

The Dow Chemical Company

filter

AUSTRIA

CHINA

FRANCE

GERMANY

INDIA

UNITED STATES

Applications: Dry binder & fast disintegrant, suitable for small tablets and ODTs, providing pleasant mouthfeel due to finer particles.

Ingredient(s): Polyvinylpyrrolidone Crosslinked

Dosage Form: Orodispersible Tablet, Tablet, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

Applications: For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.

Ingredient(s): Povidone

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP-JPE: 80 % Polyvinyl acetate and 19 % povidone, 0.8 % lauryl sulfate & 0.2 % silica (4:1)

Technical Specifications: Not Available

Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions

Ingredient(s): Hydroxypropyl Methylcellulose

Dosage Form: Tablet, Capsule

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

Applications: Moisture barrier, Multi particulates, Dry powder layering, Granulation, Hot melt extrusion, Taste Masking, Controlled / Modified Release

Ingredient(s): EthylCellulose

Dosage Form: Tablet, Orodispersible Tablet, Capsule

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

Applications: Solubiliser, Plasticizer for coating & polymeric matrices, Nonionic emulsifier for O-W emulsions.

Ingredient(s): Polyoxyl Hydogenated Castor Oil

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur: Macrogolglycerol Hydroxystearate, USP-NF: Polyoxyl 40 hydrogenated castor oil

Technical Specifications: Not Available

Applications: Wetting agent, reduces disintegration time, Ionic solubilizer, high HLB anionic emulsifier for semi-solids and foams.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

Applications: Wetting agent, reducing disintegration time, direct compression, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Sodium Lauryl Sulfate

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Sodium Laurilsulfate; USP-NF, JP: Sodium Lauryl Sulfate

Technical Specifications: Not Available

Applications: Sustained Release, Taste Masking, Moisture Barrier, Binder in Wet Granulation

Ingredient(s): Ethyl Cellulose

Dosage Form: Tablet, Capsule, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

Applications: Lipophilic lubricant, for sensitive acidic APIs, sustained release melt coating. Used as consistency factor to enhance the viscosity of topical formulations.

Ingredient(s): Hydrogenated Castor Oil

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., Castor Oil, hydrogenated, USP-NF: Hydrogenated Castor Oil, JP: Hydrogenated Oil

Technical Specifications: Not Available

Applications: Lipophilic lubricant, for sensitive acidic APIs, Structure-building consistency factor for semi-solids, Viscosity regulator.

Ingredient(s): Stearyl Alcohol

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF, JP: Stearyl Alcohol

Technical Specifications: Not Available

Applications: Lipophilic lubricant, especially for sensitive acidic APIs. Matrix forming agent in sustained-release dosage forms, emulsifying and solubilizing agent in topical formulations and hardening agent in glycerin suppositories

Ingredient(s): Stearic Acid

Dosage Form: Tablet, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

Applications: Wet Granulation and Direct Compression

Ingredient(s): Polacrilin Potassium

Dosage Form: Tablet, Orodispersible Tablet, Capsule, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

Applications: Wet Granulation and Direct Compression

Ingredient(s): Polacrilin Potassium

Dosage Form: Tablet, Orodispersible Tablet, Capsule, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available

Technical Specifications: Not Available

Applications: Ready-to-use ODT solution with superior mouthfeel.

Ingredient(s): Polyvinyl Acetate

Dosage Form: Orodispersible Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: 90 % mannitol, 5 % crospovidone, 5 % polyvinyl acetate

Technical Specifications: Not Available

Applications: Ready-to-use direct compression solution for tablets.

Ingredient(s): Crospovidone

Dosage Form: Tablet, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph.Eur., USP/NF and JP

Technical Specifications: Not Available

Applications: Ready-to-use direct compression solution for lozenges, chewables and effervescent tablets.

Ingredient(s): Povidone

Dosage Form: Tablet, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP/NF and J.P

Technical Specifications: Not Available

Applications: Increase solubility and bioavailability, Ideal for hot melt extrusion (HME)

Ingredient(s): Polyvinyl Acetate

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Polyvinyl caprolactam – polyvinyl acetate – polyethylene glycol graft copolymer

Technical Specifications: Not Available

Applications: Binder for peroxide sensitive drugs in solid oral dosage forms. Drug solubilizer with low peroxide in transdermal patches.

Ingredient(s): Povidone

Dosage Form: Granule / Pellet, Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

Applications: Tablet binding, Thickener, Stabilizers of suspensions, Reduces sedimentation, crystallization inhibition.

Ingredient(s): Povidone

Dosage Form: Tablet, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Povidone

Technical Specifications: Not Available

Applications: Roller compaction & direct compression including slight disintegration functionality, Reduces sedimentation in suspensions. Solubilizer in transdermal patches.

Ingredient(s): Polyvinylpyrrolidone Crosslinked

Dosage Form: Tablet, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP, JP: Crospovidone Type B

Technical Specifications: Not Available

Applications: Dry binder in tablets, capsules and granules, as a film-forming agent in tablet coatings and subcoatings, and as a film-forming agent in topical sprays. Widely used in HME processes.

Ingredient(s): Vinylpyrrolidone-Vinyl Acetate

Dosage Form: Tablet, Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

Applications: Binder with fine particle size for roller compaction & direct compression

Ingredient(s): Vinylpyrrolidone-Vinyl Acetate Copolymer

Dosage Form: Granule / Pellet, Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP monograph "Copovidone" and the JPE monograph "Copolyvidone"

Technical Specifications: Not Available

Applications: Nonionic emulsifier for O-W emulsions, Solubilizer

Ingredient(s): Polyoxyl 35 Castor Oil

Dosage Form: Capsule, Solution, Gel, Emulsion, Transdermal patches

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur. Macrogolglycerol Ricinoleate 35; USP-NF, JPE: Polyoxyl 35 Castor Oil

Technical Specifications: Not Available

Applications: Dissolution enhancer, lubricant & wetting agent, drug solubilizer, plasticizer, thermoreversible gelling effect.

Ingredient(s): Poloxamer 188

Dosage Form: Tablet, Capsule, Solution, Gel, Emulsion, Topical Film

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

Applications: For Instant Release Coating, Powerful and peroxide free wet binder for oxidation-sensitive drugs. Flexible and wash resistant film former in topical films.

Ingredient(s): Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Dosage Form: Tablet, Capsule, Softgels, Granule / Pellet, Topical Film

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur.: Macrogol Poly(vinyl alcohol) Grafted Copolymer; USP-NF: Ethylene Glycol and Vinyl Alcohol Graft Copolymer; JPE: Methacrylic Acid Copolymer LD

Technical Specifications: Not Available

Applications: Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Microprilled Poloxamer

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 188; JPE: Polyoxyethylene (160) Polyoxypropylene (30) glycol

Technical Specifications: Not Available

Applications: Dissolution enhancer, lubricant & wetting agent, Hydrophilic lubricant, effervescent tablets.

Ingredient(s): Microprilled Poloxamer

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Ph. Eur., USP-NF: Poloxamer 407; JPE: Polyoxyethylene (196) Polyoxypropylene (67) glyco

Technical Specifications: Not Available

Applications: Tablets, Granules, Pills, Disintegrants and fillers.

Ingredient(s): Crospovidone

Dosage Form: Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP/BP/EP/CP

Technical Specifications: Not Available

Applications: Tablets made from these granules are typically easily disintegrated using conventional super disintegrates even when hard tablets are compressed.

Ingredient(s): Microcrystalline Cellulose

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE

Technical Specifications: Not Available

Applications: Use in a wide range of oral applications such as wet or dry granulation, excipient of choice for flash release forms.

Ingredient(s): Mannitol

Dosage Form: Tablet, Capsule

Category: Granulation

Route of Administration (Grade): Topical, Oral
Pharmacopoeia Reference: Monograph- Ph.Eur, USP/NF

Technical Specifications: Available in different particle size as 25.µ, 50.µ, 180.µ

Applications: Lactose monohydrate is typically used for wet or dry granulation. During wet granulation, liquid binders or adhesives are added to the lactose and active mixture, usually by blending.

Ingredient(s): Lactose Monohydrate

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE

Technical Specifications: Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m

Applications: It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Ingredient(s): Lactose Monohydrate

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE

Technical Specifications: Sieved; Also Available as Microlex® LCM 180.s, Microlex® LCM 220.s

Applications: It is also suitable for both wet granulation and direct compression methods of tablet production. Microlex® crystalline grades are used in wet granulation and the spray dried forms are used in direct compression.

Ingredient(s): Anhydrous Lactose

Dosage Form: Tablet

Category: Granulation

Route of Administration (Grade): Oral
Pharmacopoeia Reference: Monograph- USP/NF, JP/JPE

Technical Specifications: Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m

Applications: Provides excipient benefits as a filler and filler/binder while also providing nutrient benefits as a carbohydrate source.

Ingredient(s): Corn Maltodextrins

Dosage Form: Granule / Pellet

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: EP/USP

Technical Specifications: Not Available

Applications: It provides excipient benefits as a filler/binder while also providing nutrient benefits as a carbohydrate source.

Ingredient(s): Dried Corn Glucose Syrup

Dosage Form: Tablet, Orodispersible Tablet, Granule / Pellet, Softgels

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: FCC

Technical Specifications: Not Available

Applications: It provides gentle acidification in cheese, minced meats, salad dressings and bakery products. After solubilization, GDL hydrolyzes slowly into gluconic acid.

Ingredient(s): Glucono delta lactone

Dosage Form: Tablet, Capsule, Granule / Pellet, Softgels

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP

Technical Specifications: Not Available

Applications: It provides gentle acidification in cheese, minced meats, salad dressings and bakery products. After solubilization, GDL hydrolyzes slowly into gluconic acid.

Ingredient(s): Glucono delta lactone

Dosage Form: Tablet, Capsule, Granule / Pellet, Softgels

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP

Technical Specifications: Not Available

Applications: It provides gentle acidification in cheese, minced meats, salad dressings and bakery products. After solubilization, GDL hydrolyzes slowly into gluconic acid.

Ingredient(s): Glucono delta lactone

Dosage Form: Tablet, Capsule, Granule / Pellet, Softgels

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP

Technical Specifications: Not Available

Applications: It provides nutrient benefits as a protein source for your nutraceutical product powder forms

Ingredient(s): Pea Protein

Dosage Form: Tablet, Orodispersible Tablet, Capsule, Granule / Pellet, Softgels

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: GRAS

Technical Specifications: Not Available

Applications: It provides nutrient benefits as a protein source for your nutraceutical product powder forms

Ingredient(s): Pea Protein

Dosage Form: Tablet, Orodispersible Tablet, Capsule, Granule / Pellet, Softgels

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: GRAS

Technical Specifications: Not Available

Applications: It combines nutritional and technological advantages. It forms stable emulsions.

Ingredient(s): Pea Protein

Dosage Form: Tablet, Orodispersible Tablet, Capsule, Granule / Pellet, Softgels

Category: Granulation

Route of Administration (Grade): Not Available
Pharmacopoeia Reference: GRAS

Technical Specifications: Not Available

PharmaCompass >>

First
Previous
Next
Last